Transoral robotic surgery is a exciting field that continues to develop and push the boundaries of current procedural ability and challenges historical treatment paradigms. With the first use of a surgical robot in 1985, to the first clinical use of the robot transorally in 2005, there was some lag in adoption of robotic techniques in the head and neck region. However, since 2005 transoral robotic surgery has rapidly gained momentum amongst head and neck surgeons. With FDA approval of the da Vinci robot in 2009, transoral robotic surgery is currently offered as a treatment modality for malignant and nonmalignant disease of the head and neck region. This new technology is being used to reconsider historical treatment paradigms for malignancies of the upper aerodigestive tract due to the fact that minimally invasive surgical access to the oropharynx and larynx has been improved. Along with this enhanced access have come innovative procedures and uses of the technology for multiple facets of head and neck disease. Technology continues to improve and innovation in surgical robotics is expected to continue as more companies attempt to capture this market. This article aims to provide a view at the landscape of transoral robotic surgery and explore the future frontiers.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698526 | PMC |
| http://dx.doi.org/10.1016/j.wjorl.2016.05.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case presentation of a robot-assisted bilateral benign tonsillectomy using the da Vinci SP system.
J Surg Case Rep
January 2025
Department of Otolaryngology, Head and Neck Surgery, University Medical Center Mainz, Langenbeckstraße 1, 55131, Mainz, Germany.
The Role of TORS in the Management of Benign Pathology of the Base of Tongue: A Systematic Review.
Diagnostics (Basel)
December 2024
Unit of Otolaryngology, Head and Neck Department, University of Verona, P.le L.A. Scuro 10, 37134 Verona, Italy.
Objective: Transoral robotic surgery (TORS) is becoming increasingly popular in head and neck surgery. Its applications have expanded beyond oncologic indications to obstructive sleep apnea syndrome (OSAS) and, more recently, to benign pathologies.
Data Sources: A systematic search for articles published in the PubMed and Google Scholar databases between January 2003 and December 2023 was performed using the following combined search query (robot OR sleep OR apnea OR syndrome) AND (robot OR tongue OR base).
Functional and oncological outcomes of transoral laser versus robotic surgery in supraglottic squamous cell carcinoma.
Oral Oncol
January 2025
Department of Otolaryngology - Head & Neck Surgery Foch Hospital Suresnes France; School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), 2 Av. de la Source de la Bièvre 78 180 Montigny-le-Bretonneux, France; Phonetics and Phonology Laboratory (UMR 7018 CNRS & Université Sorbonne nouvelle), Paris, France.
Objective: To compare the surgical, functional and oncological outcomes of Transoral Laser Microsurgery (TLM) and Transoral Robotic Surgery (TORS) for the treatment of supraglottic squamous cell carcinoma.
Study Design: Retrospective case series with prospective data.
Settings: Tertiary Academic Medical Center.
Transoral Robotic Surgery for Patients with Obstructive Sleep Apnoea: A Systematic Literature Review of Current Practices.
Life (Basel)
December 2024
ENT Department, University Hospital of Alexandroupolis, Democritus University of Thrace-Medical School, 68100 Alexandroupolis, Greece.
Transoral robotic surgery (TORS) for tongue base reduction (TBR) and/or epiglottic surgery is an effective treatment option for selected patients with moderate to severe obstructive sleep apnoea (OSA). This systematic review aims to provide an up-to-date overview of current practices and challenges associated with TORS for OSA. PubMed and Embase databases were searched up to December 2022 following PRISMA guidelines.
View Article and Find Full Text PDFThe effectiveness of unimodality organ preservation surgical vs organ preservation radiotherapy for early hypopharyngeal cancer: a systematic review protocol.
JBI Evid Synth
January 2025
JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Objective: Our aim is to determine the comparative effectiveness of unimodality organ preservation surgery versus radiotherapy on oncological and functional outcomes in patients with early hypopharyngeal cancer.
Introduction: Early hypopharyngeal cancer is difficult to detect and therefore rarely diagnosed, as patients are often asymptomatic. Radiotherapy is considered the main treatment, although this modality has been compared to the previously used open surgical approach, which may not reflect current surgical options.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!